Chapter·BiostatisticsPower and sample size

Power calculations for subgroup analysesDownloads

10Questions
10Flashcards
2Tables & Flowcharts

Study Materials

Practice

Sample Questions

1

A research team develops a new monoclonal antibody checkpoint inhibitor for advanced melanoma that has shown promise in animal studies as well as high efficacy and low toxicity in early phase human clinical trials. The research team would now like to compare this drug to existing standard of care immunotherapy for advanced melanoma. The research team decides to conduct a non-randomized study where the novel drug will be offered to patients who are deemed to be at risk for toxicity with the current standard of care immunotherapy, while patients without such risk factors will receive the standard treatment. Which of the following best describes the level of evidence that this study can offer?

ALevel 1

BLevel 3

CLevel 5

DLevel 4

ELevel 2

2

You are conducting a study comparing the efficacy of two different statin medications. Two groups are placed on different statin medications, statin A and statin B. Baseline LDL levels are drawn for each group and are subsequently measured every 3 months for 1 year. Average baseline LDL levels for each group were identical. The group receiving statin A exhibited an 11 mg/dL greater reduction in LDL in comparison to the statin B group. Your statistical analysis reports a p-value of 0.052. Which of the following best describes the meaning of this p-value?

AThere is a 95% chance that the difference in reduction of LDL observed reflects a real difference between the two groups

BThough A is more effective than B, there is a 5% chance the difference in reduction of LDL between the two groups is due to chance

CIf 100 permutations of this experiment were conducted, 5 of them would show similar results to those described above

DThis is a statistically significant result

EThere is a 5.2% chance of observing a difference in reduction of LDL of 11 mg/dL or greater even if the two medications have identical effects

3

A 25-year-old man with a genetic disorder presents for genetic counseling because he is concerned about the risk that any children he has will have the same disease as himself. Specifically, since childhood he has had difficulty breathing requiring bronchodilators, inhaled corticosteroids, and chest physiotherapy. He has also had diarrhea and malabsorption requiring enzyme replacement therapy. If his wife comes from a population where 1 in 10,000 people are affected by this same disorder, which of the following best represents the likelihood a child would be affected as well?

A0.01%

B2%

C0.5%

D1%

E50%

+ 7 more in the PDF

More Power and sample size downloads

Browse all chapters

View all